TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $328,000 | -58.9% | 77,224 | -8.0% | 0.02% | -64.4% |
Q1 2022 | $798,000 | +159.1% | 83,924 | +417.7% | 0.04% | +309.1% |
Q4 2021 | $308,000 | -70.8% | 16,210 | -40.5% | 0.01% | -75.6% |
Q2 2021 | $1,056,000 | +213.4% | 27,227 | +116.1% | 0.04% | +21.6% |
Q3 2020 | $337,000 | +54.6% | 12,600 | +12.5% | 0.04% | +2.8% |
Q2 2020 | $218,000 | -73.0% | 11,200 | -86.4% | 0.04% | -63.3% |
Q1 2020 | $808,000 | +64.9% | 82,100 | +86.2% | 0.10% | +145.0% |
Q4 2019 | $490,000 | – | 44,100 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |